IVVD 1 (-7.41%)
US00534A1025BiotechnologyBiotechnology

Invivyd (IVVD) Stock Highlights

1 | -7.41%
2024-08-08 04:35:39
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The companys lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.

Statistics

Range Today
1 1.08
Volume Today 203.9K
Range 1 Year
1 5.2
Volume 1 Year 199.47M
Range 3 Year
0.98 78.82
Volume 3 Year 1.14B
Range 10 Year
0.98 78.82
Volume 10 Year 1.14B

Highlights

Market Capitalization 136.02M (small)
Floating Shares 45.46M
Current Price 1
Price To Earnings -0.61
Price To Book 0.76
Earnings Per Share -1.87
Payout Ratio 0%

Performance

Latest -7.41%
1 Month -13.79%
3 Months -57.81%
6 Months -79.51%
1 Year -31.03%
3 Years -95.39%
5 Years -95.24%
10 Years -95.24%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.